- Accueil >
- Publications >
- Preliminary results of the concurrent use of radiotherapy for bone metastases and trastuzumab emtansine in patients with HER2-positive metastatic breast cancer
Preliminary results of the concurrent use of radiotherapy for bone metastases and trastuzumab emtansine in patients with HER2-positive metastatic breast cancer
Auteurs
A. Géraud, H.P. Xu, P. Beuzeboc, Y.M. Kirova